Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise

HOVIONE

PR99735

 

LISBON, Portugal, March 8, 2023 /PRNewswire=KYODO JBN/--

 

Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO

Leadership Award (https://www.cmoleadershipawards.com/) across all six

categories – capability, compatibility, expertise, quality, reliability and

service across all three groups of respondents (Big Pharma, Small Pharma, and

Overall (combined Big and Small Pharma)). Hovione was given additional

recognition as a CDMO Leadership Award Champion in the categories of

Compatibility and Expertise for scoring as a top performer in comparison to the

weighted average of other CDMOs included in the Industry Standard Research

(ISR)’s annual Contract Manufacturing Quality Benchmarking survey.

 

Established in 2011 by Outsourced Pharma and Life Science Leader, the CDMO

Leadership Awards spotlight excellence in Capabilities, Expertise, Quality,

Compatibility, Reliability and Service. The CDMO Leadership Awards teamed up

with ISR to determine the award recipients - 72 contract manufacturers were

assessed by 23 performance metrics in ISR’s annual Contract Manufacturing

Quality Benchmarking survey.

 

"We are honored and proud to receive this award in all six categories. This

broad recognition reflects the dedication of our team to help our customers

deliver much-needed medicines to the market," said Dr. Jean-Luc Herbeaux,

Hovione’s CEO. “This is not the first time Hovione is recognized by the CDMO

Leadership awards and winning these awards once again reinforces our commitment

to excellence and differentiation in the services we provide to our customers.”

 

“For over a decade, these awards have been the most meaningful for biopharma

organizations striving to obtain optimal outcomes from their outsourcing

activities. Our research arm, ISR Reports, which only surveys drug sponsors who

have worked directly and recently with specific CDMOs, ensures the validity of

these results. Our winners are your gold medalists of outsourcing,” said Louis

Garguilo, Chief Editor and Conference Chair of Outsourced Pharma.

 

Hovione has been expanding

(https://www.hovione.com/press-room/press-release/hovione-invests-170-million-ne

w-capacity-and-capabilities) worldwide, demonstrating the commitment to its

customers. Hovione has been investing in new laboratory and production assets

and innovative technologies

(https://www.hovione.com/press-room/press-release/hovione-expands-drug-product-o

ffering-new-manufacturing-line-dedicated-continuous-tableting) to meet customer

demand for integrated and differentiated services in manufacturing of drug

substances, particles and drug products.

 

About Hovione:

Hovione is an international company with over 60 years of experience in

pharmaceutical development and manufacturing operations. As a Contract

Development and Manufacturing Organization (CDMO)

(https://go.hovione.com/e/47122/ontract-manufacturing-services/8wjzq5/2436741121

?h=xIUzj2eUnalGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) with a fully integrated

offering of services for drug substances, drug product intermediates and drug

products. The company has four FDA inspected sites

(https://go.hovione.com/e/47122/hovione-worldwide/8wjzq8/2436741121?h=xIUzj2eUna

lGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) in the USA, Portugal, Ireland and China and

development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione

provides pharmaceutical customers services for the development and compliant

manufacture

(https://go.hovione.com/e/47122/-services-particle-engineering/8wjzqc/2436741121

?h=xIUzj2eUnalGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) of innovative drugs, including

highly potent compounds, and customized product solutions across the entire

drug life cycle. In the inhalation area, Hovione offers a complete range of

services, from API, formulation development and devices. Hovione´s culture is

based on innovation, quality and dependability. Hovione was the first Chemical/

Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360,

EFCG and participates actively in industry quality improvement initiatives to

lead new global industry standards.

 

For more information, please visit www.hovione.com (http://www.hovione.com/) or

contact:

Vanessa Romeu | Communications Director | vromeu@hovione.com |Tel: +351 21 982

9000

 

Photo: https://mma.prnewswire.com/media/2018547/HOVIONE.jpg

 

Source: HOVIONE

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中